World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   631 records for 131 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingNCT02931955
Applying Systems Immunology to the Search for Personalized Biomarkers of Clinical Efficacy
03/10/2016
Not recruitingNCT02908308
Hypothermia or Normothermia-Targeted Temperature Management After Out-of-hospital Cardiac Arrest-trial
16/09/2016
RecruitingISRCTN13716228
everyBody – Tailored online health promotion and eating disorder prevention for women at different risk stages
26/02/2016
AuthorisedEUCTR2015-003447-19-GB
A Phase 3 Multicenter Open-label Study of Brigatinib versus Crizotinib in ALK-positive Advanced Lung Cancer patients 23/02/2016
RecruitingNCT02699736
Clinical and Virological Outcome of European Patients Infected With HIV
19/01/2016
AuthorisedEUCTR2015-002899-25-EE
Safety and Efficacy study of QVM149 in asthmatic patients
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-002899-25-PTSafety and Efficacy study of QVM149 in asthmatic patients07/12/2015
AuthorisedEUCTR2015-002899-25-GRSafety and Efficacy study of QVM149 in asthmatic patients08/02/2016
AuthorisedEUCTR2015-002899-25-LVSafety and Efficacy study of QVM149 in asthmatic patients11/01/2016
AuthorisedEUCTR2015-002899-25-DKSafety and Efficacy study of QVM149 in asthmatic patients08/01/2016
AuthorisedEUCTR2015-002899-25-SKSafety and Efficacy study of QVM149 in asthmatic patients07/12/2015
AuthorisedEUCTR2015-002899-25-ATSafety and Efficacy study of QVM149 in asthmatic patients15/12/2015
AuthorisedEUCTR2015-002899-25-LTSafety and Efficacy study of QVM149 in asthmatic patients04/12/2015
AuthorisedEUCTR2015-002899-25-ESSafety and Efficacy study of QVM149 in asthmatic patients07/01/2016
AuthorisedEUCTR2015-002899-25-BGSafety and Efficacy study of QVM149 in asthmatic patients13/04/2016
AuthorisedEUCTR2015-002899-25-HRSafety and Efficacy study of QVM149 in asthmatic patients06/07/2016
AuthorisedEUCTR2015-002899-25-DESafety and Efficacy study of QVM149 in asthmatic patients04/12/2015
AuthorisedEUCTR2015-002899-25-BESafety and Efficacy study of QVM149 in asthmatic patients04/01/2016
AuthorisedEUCTR2015-002899-25-HUSafety and Efficacy study of QVM149 in asthmatic patients16/12/2015
AuthorisedEUCTR2015-002899-25-NLSafety and Efficacy study of QVM149 in asthmatic patients17/12/2015
AuthorisedEUCTR2015-002899-25-FISafety and Efficacy study of QVM149 in asthmatic patients23/12/2015
28/11/2015
RecruitingNCT02607878
Automated Pupillometry for Coma Prognostication After Cardiac Arrest
02/11/2015
RecruitingNCT02588144
Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's Disease
24/10/2015
RecruitingNCT02571777
Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
Recruitment statusMain IDPublic titleDate of registration
RecruitingJPRN-JapicCTI-163283Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma07/06/2016
RecruitingCTRI/2016/06/007062Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma30-06-2016
05/10/2015
AuthorisedEUCTR2015-001088-38-FI
A study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-001088-38-ESA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.05/11/2015
AuthorisedEUCTR2015-001088-38-PLA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.16/02/2016
AuthorisedEUCTR2015-001088-38-CZA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.12/10/2015
AuthorisedEUCTR2015-001088-38-GBA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.12/11/2015
AuthorisedEUCTR2015-001088-38-BEA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.01/10/2015
AuthorisedEUCTR2015-001088-38-DEA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.23/09/2015
RecruitingNCT02626455Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)03/11/2015
AuthorisedEUCTR2015-001088-38-DKA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.03/11/2015
21/09/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history